InMode Ltd Market Cap ($810.22 Million)
Market Cap & Net Worth: InMode Ltd (INMD)
InMode Ltd market cap. InMode Ltd (NASDAQ:INMD) has a market capitalization of $810.22 Million ($810.22 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9469 globally and #2650 in its home market, demonstrating a 2.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InMode Ltd's stock price $14.08 by its total outstanding shares 57544172 (57.54 Million). Also see InMode Ltd (INMD) cash conversion ratio for how efficiently the company converts equity into cash flow.
InMode Ltd Market Cap History (2019–2026)
InMode Ltd market cap history from 2019 to 2026. Data shows growth from $1.13 Billion to $810.22 Million (10.60% CAGR). Check InMode Ltd stock quote for real-time trading data and today's change.
Index Memberships
InMode Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.03% | #273 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1008 of 3165 |
Weight: InMode Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
InMode Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InMode Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore InMode Ltd (INMD) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.28x
InMode Ltd's market cap is 2.28 times its annual revenue
Latest Price to Earnings (P/E) Ratio
9.01x
InMode Ltd's market cap is 9.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.13 Billion | $156.36 Million | $61.15 Million | 7.21x | 18.45x |
| 2020 | $1.37 Billion | $206.11 Million | $75.03 Million | 6.63x | 18.21x |
| 2021 | $4.06 Billion | $357.56 Million | $164.97 Million | 11.36x | 24.62x |
| 2022 | $2.05 Billion | $454.27 Million | $161.52 Million | 4.52x | 12.72x |
| 2023 | $1.28 Billion | $492.05 Million | $197.92 Million | 2.60x | 6.47x |
| 2024 | $960.99 Million | $394.82 Million | $181.28 Million | 2.43x | 5.30x |
| 2025 | $845.32 Million | $370.50 Million | $93.83 Million | 2.28x | 9.01x |
Competitor Companies of INMD by Market Capitalization
Companies near InMode Ltd in the global market cap rankings as of November 5, 2026. Also see INMD total assets for a full breakdown of the balance sheet.
Key companies related to InMode Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of InMode Ltd (2019–2026)
Market capitalization of InMode Ltd from 2019 to today. Between 2019 and today, InMode Ltd's market cap moved from $1.13 Billion to $ 810.22 Million, with a yearly change of 10.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $810.22 Million | -4.15% |
| 2025 | $845.32 Million | -12.04% |
| 2024 | $960.99 Million | -24.91% |
| 2023 | $1.28 Billion | -37.70% |
| 2022 | $2.05 Billion | -49.42% |
| 2021 | $4.06 Billion | +197.30% |
| 2020 | $1.37 Billion | +21.12% |
| 2019 | $1.13 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of InMode Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $810.22 Million USD |
| MoneyControl | $810.22 Million USD |
| MarketWatch | $810.22 Million USD |
| marketcap.company | $810.22 Million USD |
| Reuters | $810.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About InMode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous ski… Read more